Therapeutics Hormonal Agents

Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes, and androgen receptor behavior

Moghetti P, Castello R, Negri C, Tosi F, Magnani CM, Fontanarosa MC, Armanini D, Muggeo M

Published September 1995 Fertility and Sterility, 64(3), 511-517
DOI 10.1016/s0015-0282(16)57785-1 PMID 7641903

RRM Academy Synopsis

Flutamide lowered hirsutism scores in 18 women over 12 months

Flutamide lowered hirsutism scores over 12 months in women with regular menses. Cycles stayed ovulatory in all 18 women. One woman developed liver injury that reversed after she stopped the drug. In 10 women, a monthly rhythm in androgen receptors on white blood cells was gone after 4 months of treatment.

Study at a glance, prospective study: Flutamide lowered hirsutism scores in 18 women over 12 months
Study at a glance, prospective study of 18 women with hirsutism: Flutamide lowered hirsutism scores in 18 women over 12 months. Source: Moghetti P et al., 1995, PMID 7641903.

Key Findings

  • The modified Ferriman-Gallwey hirsutism score fell from 14.1 ± 0.9 to 4.1 ± 0.5 after 1 year of flutamide (mean ± SEM). No woman used cosmetic hair removal from month 6 on.
  • In self-ratings of the result, 10 women reported excellent, 5 satisfactory and 1 poor. Acne disappeared within 3 months in all four women who had it.
  • One woman left the study after 8 months because of liver injury, which completely reversed within 3 months of stopping flutamide. Two women reported dry skin and one reported decreased libido.
  • None of the women had abnormal menses, and serial progesterone showed all remained ovulatory. Total testosterone fell, whereas free testosterone did not change significantly.
  • In 10 women, androgen receptor number in white blood cells was higher in the luteal than the follicular phase before treatment. That difference was absent after 4 months of flutamide.

Interpretation

This prospective study followed 18 women with hirsutism and regular menses through 12 months of flutamide treatment. All 18 had regular menses, and ovulation was demonstrated in each. The authors state that liver function should be monitored monthly during treatment. The authors note that the meaning of the receptor change remains to be elucidated. The findings support larger studies of this antiandrogen approach for hirsutism.

RRM Context

Before treatment, the authors checked every woman for adrenal, prolactin, thyroid and glucose problems. They also showed that each woman ovulated. Restorative reproductive medicine asks the same first question: what is causing the extra androgen? The authors say flutamide needs careful birth control, since it could harm a male baby. Sexually active women used barrier or IUD birth control.

Abstract

Objective

To investigate the long-term effects of treatment with low doses of flutamide on clinical and hormonal parameters, as well as on the androgen receptor status, in hirsute women.

Design

Eighteen hirsute patients with regular menses were studied basally and during treatment with 125 mg flutamide, three times per day for 12 months. Barrier or intrauterine contraception was used during the study in sexually active women. Safety parameters were assessed throughout the study. Hirsutism, graded by the modified Ferriman-Gallwey score, and hormonal parameters were evaluated basally and at 4-month intervals during treatment. Gonadotropin-releasing hormone and ACTH stimulation tests were performed before and after 3 to 4 months of therapy. In addition, the concentration of androgen receptors in mononuclear leukocytes was measured, in both the follicular and luteal phases of the menstrual cycle, basally and after 4 months of flutamide treatment.

Results

Flutamide was well tolerated in all women, with the noticeable exception of one patient who presented increased serum transaminase after 8 months of therapy. Hirsutism markedly improved in all women during the treatment (Ferriman-Gallwey score after 1 year: 4.1 +/- 0.5 versus 14.1 +/- 0.9). A reduction of serum androgens was found, whereas no change was observed in either basal or GnRH-stimulated gonadotropins or in the cortisol and 17 alpha-hydroxyprogesterone response to ACTH. Cycles remained ovulatory. Before treatment, the number of androgen receptors was higher in the luteal than in the follicular phase. This rhythmic differentiation disappeared after the patients had been given the antiandrogen drug.

Conclusions

Flutamide is effective in the treatment of hirsutism but requires constant surveillance of liver function. Androgen receptor blockade might be potentiated by a reduction of serum androgens. Flutamide affects androgen receptor behavior during the menstrual cycle. The meaning of this finding remains to be elucidated.

Topics

By this author

Related research

Therapeutics › Hormonal Agents › Androgens and DHEA
Paolo Moghetti, Roberto Castello, Carlo Negri, Flavia Tosi, Chiara M. Magnani, M. Cristina Fontanarosa, Decio Armanini, Michele Muggeo
P Moghetti, R Castello, C Negri, F Tosi, C Magnani, D Armanini, M Muggeo
PMID 7641903 7641903 DOI 10.1016/s0015-0282(16)57785-1 10.1016/s0015-0282(16)57785-1 Moghetti et al. 1995, Moghetti 1995